Advertisement
Screener

Seres Therapeutics, Inc. (MCRB) Inventory, Raw Materials, Gross

2.8 / 5 stars · 68/120 Roast Me

Seres Therapeutics, Inc. Inventory, Raw Materials, Gross

Seres Therapeutics, Inc. (MCRB) had Inventory, Raw Materials, Gross of $4.93 million as of 2024-06-30, per its 10-Q filed 2024-08-13.

Discontinued › Notes

us-gaap:InventoryRawMaterials · last filed 2024-08-15

  • 2024-06-30: Inventory, Raw Materials, Gross $4.93M.
  • 2024-03-31: Inventory, Raw Materials, Gross $4.22M.
  • 2023-12-31: Inventory, Raw Materials, Gross $4.43M.
  • 2023-09-30: Inventory, Raw Materials, Gross $3.53M.
Period endInventory, Raw Materials, Gross
2024-06-30$4.93M
10-Q · filed 2024-08-13
2024-03-31$4.22M
10-Q · filed 2024-05-08
2023-12-31$4.43M
8-K · filed 2024-08-15
2023-09-30$3.53M
10-Q · filed 2023-11-02
2023-06-30$547.00K
10-Q · filed 2023-08-08
2022-12-31$0.00
8-K · filed 2024-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
BriaCell Therapeutics Corp. (BCTX)$0.037B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
Edesa Biotech, Inc. (EDSA)Canada$0.039B